HIGH

Major Pharmaceuticals Chlorpromazine Hydrochloride 50 mg Tablets Recalled for Nitrosamine Impurity (

Major Pharmaceuticals, via The Harvard Drug Group LLC, recalled 506 blister packs of Chlorpromazine Hydrochloride tablets, 50 mg, distributed nationwide. A CGMP deviation shows the presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit. Stop using the product and contact the Harvard Drug Group or Rugby Laboratories for guidance.

Quick Facts at a Glance

Recall Date
September 12, 2025
Hazard Level
HIGH
Brands
Major Pharmaceuticals, Chlorpromazine Hydrochloride
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Chlorpromazine hydrochloride is a prescription antipsychotic used for certain psychiatric conditions. The recalled lots were packaged as 50 mg tablets in 10x10 blister packs and distributed nationwide.

Why This Is Dangerous

The impurity N-Nitroso Desmethyl Chlorpromazine was found above the recommended intake limit due to CGMP deviations in manufacturing. Prolonged exposure to nitrosamine impurities can pose health risks.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers prescribed this drug should stop using the affected lots and contact their healthcare provider. The recall covers 506 blister packs nationwide and may affect patients who rely on this medication for treatment.

Practical Guidance

How to identify if yours is affected

  1. Check NDC 0904-7131-61 on the bottle label.
  2. Verify model numbers N02009 or N02026 on the packaging.
  3. Look for 50 mg dosage in a (10x10) blister pack.
  4. Confirm packaging type and UPC if present.

Where to find product info

FDA enforcement page for recall D-0011-2026 and the distributor’s recall notice.

What timeline to expect

Refunds or replacements, if offered, typically take 4-8 weeks.

If the manufacturer is unresponsive

  • Document all contact attempts with the distributor.
  • File a complaint with the FDA or state consumer protection agency if no response is received.
  • Consult your healthcare provider for interim alternatives.

How to prevent similar issues

  • When buying prescription medications, verify CGMP compliance and recall status.
  • Check NDC codes before use.
  • Keep packaging and recall notices until resolved.

Documentation advice

Retain the product packaging, recall notice, and any correspondence with the distributor and your healthcare provider for records.

Product Details

Model numbers: N02009, N02026. NDC: 0904-7131-61. UPC: (01)00309047131617. Quantity: 506 blister packs. Distribution: Nationwide. Sold at: Unknown. Price: Unknown.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 506 blister packs recalled
  • NDC 0904-7131-61
  • Model numbers N02009 and N02026
  • Nitrosamine impurity above intake limit
  • Nationwide distribution
  • No injuries reported

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
POISONING

Product Classification

Product Details

Model Numbers
N02009
N02026
UPC Codes
0904-7129
0904-7130
0904-7131
+9 more
Affected States
ALL
Report Date
October 15, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more